Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis von ALTMANN, D. R, JASPERSE, B, WAGNER, K, YOUSRY, T. A, MILLER, D. H, BARKHOF, F, BECKMANN, K, FILIPPI, M, KAPPOS, L. D, MOLYNEUX, P, POLMAN, C. H, POZZILLI, C, THOMPSON, A. J

Volltext

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis von Hauser, Stephen L, Bar-Or, Amit, Comi, Giancarlo, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Montalban, Xavier, Rammohan, Kottil W, Selmaj, Krzysztof, Traboulsee, Anthony, Wolinsky, Jerry S, Arnold, Douglas L, Klingelschmitt, Gaelle, Masterman, Donna, Fontoura, Paulo, Belachew, Shibeshih, Chin, Peter, Mairon, Nicole, Garren, Hideki, Kappos, Ludwig

Volltext

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis von Montalban, Xavier, Hauser, Stephen L, Kappos, Ludwig, Arnold, Douglas L, Bar-Or, Amit, Comi, Giancarlo, de Seze, Jérôme, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Rammohan, Kottil W, Selmaj, Krzysztof, Traboulsee, Anthony, Sauter, Annette, Masterman, Donna, Fontoura, Paulo, Belachew, Shibeshih, Garren, Hideki, Mairon, Nicole, Chin, Peter, Wolinsky, Jerry S

Volltext

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines von Filippi, Massimo, Prof, Rocca, Maria A, MD, Ciccarelli, Olga, Prof, De Stefano, Nicola, MD, Evangelou, Nikos, PhD, Kappos, Ludwig, Prof, Rovira, Alex, MD, Sastre-Garriga, Jaume, MD, Tintorè, Mar, MD, Frederiksen, Jette L, Prof, Gasperini, Claudio, MD, Palace, Jacqueline, MD, Reich, Daniel S, MD, Banwell, Brenda, Prof, Montalban, Xavier, Prof, Barkhof, Frederik, Prof

Volltext

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis von Disanto, Giulio, Barro, Christian, Benkert, Pascal, Naegelin, Yvonne, Schädelin, Sabine, Giardiello, Antonella, Zecca, Chiara, Blennow, Kaj, Zetterberg, Henrik, Leppert, David, Kappos, Ludwig, Gobbi, Claudio, Kuhle, Jens, Kuhle, Jens, Lorscheider, Johannes, Yaldizli, Özgür, Derfuss, Tobias, Kappos, Ludwig, Disanto, Giulio, Zecca, Chiara, Gobbi, Claudio, Benkert, Pascal, Achtnichts, Lutz, Nedeltchev, Krassen, Kamm, Christian P, Salmen, Anke, Chan, Andrew, Lalive, Patrice H, Pot, Caroline, Schluep, Myriam, Granziera, Cristina, Du Pasquier, Renaud, Müller, Stefanie, Vehoff, Jochen

Volltext

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis von Comi, Giancarlo, Jeffery, Douglas, Kappos, Ludwig, Montalban, Xavier, Boyko, Alexey, Rocca, Maria A, Filippi, Massimo

Volltext

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis von O'Connor, Paul, Wolinsky, Jerry S, Confavreux, Christian, Comi, Giancarlo, Kappos, Ludwig, Olsson, Tomas P, Benzerdjeb, Hadj, Truffinet, Philippe, Wang, Lin, Miller, Aaron, Freedman, Mark S

Volltext

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial von Confavreux, Christian, Prof, O'Connor, Paul, Prof, Comi, Giancarlo, Prof, Freedman, Mark S, Prof, Miller, Aaron E, Prof, Olsson, Tomas P, Prof, Wolinsky, Jerry S, Prof, Bagulho, Teresa, MD, Delhay, Jean-Luc, MD, Dukovic, Deborah, MS, Truffinet, Philippe, MD, Kappos, Ludwig, Prof

Volltext

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis von Montalban, Xavier, Gold, Ralf, Thompson, Alan J, Otero-Romero, Susana, Amato, Maria Pia, Chandraratna, Dhia, Clanet, Michel, Comi, Giancarlo, Derfuss, Tobias, Fazekas, Franz, Hartung, Hans Peter, Havrdova, Eva, Hemmer, Bernhard, Kappos, Ludwig, Liblau, Roland, Lubetzki, Catherine, Marcus, Elena, Miller, David H, Olsson, Tomas, Pilling, Steve, Selmaj, Krysztof, Siva, Aksel, Sorensen, Per Soelberg, Sormani, Maria Pia, Thalheim, Christoph, Wiendl, Heinz, Zipp, Frauke

Volltext

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis von Kappos, Ludwig, Wiendl, Heinz, Selmaj, Krzysztof, Arnold, Douglas L, Havrdova, Eva, Boyko, Alexey, Kaufman, Michael, Rose, John, Greenberg, Steven, Sweetser, Marianne, Riester, Katherine, O’Neill, Gilmore, Elkins, Jacob

Volltext

Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis von Manouchehrinia, Ali, Stridh, Pernilla, Khademi, Mohsen, Leppert, David, Barro, Christian, Michalak, Zuzanna, Benkert, Pascal, Lycke, Jan, Alfredsson, Lars, Kappos, Ludwig, Piehl, Fredrik, Olsson, Tomas, Kuhle, Jens, Kockum, Ingrid

Volltext

Genetics of multiple sclerosis: swimming in an ocean of data von Baranzini, Sergio E, Nickles, Dorothee

Volltext

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria von Thompson, Alan J, Banwell, Brenda L, Barkhof, Frederik, Carroll, William M, Coetzee, Timothy, Comi, Giancarlo, Correale, Jorge, Fazekas, Franz, Filippi, Massimo, Freedman, Mark S, Fujihara, Kazuo, Galetta, Steven L, Hartung, Hans Peter, Kappos, Ludwig, Lublin, Fred D, Marrie, Ruth Ann, Miller, Aaron E, Miller, David H, Montalban, Xavier, Mowry, Ellen M, Sorensen, Per Soelberg, Tintoré, Mar, Traboulsee, Anthony L, Trojano, Maria, Uitdehaag, Bernard M J, Vukusic, Sandra, Waubant, Emmanuelle, Weinshenker, Brian G, Reingold, Stephen C, Cohen, Jeffrey A

Volltext

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial von Miller, Aaron E, Prof, Wolinsky, Jerry S, Prof, Kappos, Ludwig, MD, Comi, Giancarlo, Prof, Freedman, Mark S, Prof, Olsson, Tomas P, Prof, Bauer, Deborah, MS, Benamor, Myriam, MD, Truffinet, Philippe, MD, O'Connor, Paul W, Prof

Volltext

Mitochondrial changes within axons in multiple sclerosis: an update von Campbell, Graham R, Ohno, Nobuhiko, Turnbull, Doug M, Mahad, Don J

Volltext

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study von Benkert, Pascal, Meier, Stephanie, Schaedelin, Sabine, Manouchehrinia, Ali, Yaldizli, Özgür, Maceski, Aleksandra, Oechtering, Johanna, Achtnichts, Lutz, Conen, David, Derfuss, Tobias, Lalive, Patrice H, Mueller, Christian, Müller, Stefanie, Naegelin, Yvonne, Oksenberg, Jorge R, Pot, Caroline, Salmen, Anke, Willemse, Eline, Kockum, Ingrid, Blennow, Kaj, Zetterberg, Henrik, Gobbi, Claudio, Kappos, Ludwig, Wiendl, Heinz, Berger, Klaus, Sormani, Maria Pia, Granziera, Cristina, Piehl, Fredrik, Leppert, David, Kuhle, Jens, Aeschbacher, Stefanie, Barakovic, Muhamed, Buser, Andreas, Chan, Andrew, Disanto, Giulio, D'Souza, Marcus, Du Pasquier, Renaud, Findling, Oliver, Galbusera, Riccardo, Hrusovsky, Kevin, Khalil, Michael, Lorscheider, Johannes, Mathias, Amandine, Orleth, Annette, Radue, Ernst-Wilhelm, Rahmanzadeh, Reza, Sinnecker, Tim, Subramaniam, Suvitha, Vehoff, Jochen, Wellmann, Sven, Wuerfel, Jens, Zecca, Chiara

Volltext

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis von Kappos, Ludwig, Radue, Ernst-Wilhelm, O'Connor, Paul, Polman, Chris, Hohlfeld, Reinhard, Calabresi, Peter, Selmaj, Krzysztof, Agoropoulou, Catherine, Leyk, Malgorzata, Zhang-Auberson, Lixin, Burtin, Pascale

Volltext

Differential diagnosis of suspected multiple sclerosis: a consensus approach von Miller, DH, Weinshenker, BG, Filippi, M, Banwell, BL, Cohen, JA, Freedman, MS, Galetta, SL, Hutchinson, M, Johnson, RT, Kappos, L, Kira, J, Lublin, FD, McFarland, HF, Montalban, X, Panitch, H, Richert, JR, Reingold, SC, Polman, CH

Volltext

Clinical outcomes of natalizumab- associated progressive multifocal leukoencephalopathy von VERMERSCH, P, KAPPOS, L, GOLD, R, FOLEY, J. F, OLSSON, T, CADAVID, D, BOZIC, C, RICHMAN, S

Volltext

Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome von Kuhle, Jens, Gaiottino, Johanna, Leppert, David, Petzold, Axel, Bestwick, Jonathan P, Malaspina, Andrea, Lu, Ching-Hua, Dobson, Ruth, Disanto, Giulio, Norgren, Niklas, Nissim, Ahuva, Kappos, Ludwig, Hurlbert, John, Yong, V Wee, Giovannoni, Gavin, Casha, Steven

Volltext